Approved Symbol |
Approved Name |
Location |
Source |
NOMO3 |
NODAL modulator 3 |
16p13 |
Mapped by CNV; Mapped by significant region |
XYLT1 |
xylosyltransferase I |
16p12 |
Mapped by CNV; Mapped by significant region |
RPL17P40 |
ribosomal protein L17 pseudogene 40 |
16p13 |
Mapped by CNV; Mapped by significant region |
RPL15P20 |
ribosomal protein L15 pseudogene 20 |
16p13.11 |
Mapped by CNV; Mapped by significant region |
ABCC6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
16p13.11 |
Mapped by CNV; Mapped by significant region |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
16p13.1 |
Mapped by CNV; Mapped by significant region |
NDE1 |
nudE nuclear distribution gene E homolog 1 (A. nidulans) |
16p13.11 |
Mapped by CNV; Mapped by significant region |
PKD1P1 |
polycystic kidney disease 1 (autosomal dominant) pseudogene 1 |
16p13 |
Mapped by CNV; Mapped by significant region |
PKD1P2 |
polycystic kidney disease 1 (autosomal dominant) pseudogene 2 |
16p13.11 |
Mapped by CNV; Mapped by significant region |
RPL7P47 |
ribosomal protein L7 pseudogene 47 |
16p12.3 |
Mapped by CNV; Mapped by significant region |
MYH11 |
myosin, heavy chain 11, smooth muscle |
16p13.11 |
Mapped by CNV; Mapped by significant region |
KIAA0430 |
KIAA0430 |
16p13.11 |
Mapped by CNV; Mapped by significant region |
C16orf45 |
chromosome 16 open reading frame 45 |
16p13.2 |
Mapped by CNV; Mapped by significant region |
MIR3179-2 |
microRNA 3179-2 |
16 |
Mapped by CNV; Mapped by significant region |
MIR3180-2 |
microRNA 3180-2 |
16 |
Mapped by CNV; Mapped by significant region |
MIR484 |
microRNA 484 |
16p13.11 |
Mapped by CNV; Mapped by significant region |
FOPNL |
FGFR1OP N-terminal like |
16p13.11 |
Mapped by CNV; Mapped by significant region |
MPV17L |
MPV17 mitochondrial membrane protein-like |
16p13.11 |
Mapped by CNV; Mapped by significant region |